AIFF Insider Trading
Insider Ownership Percentage: 6.44%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $1,015,774.96
Firefly Neuroscience Share Price & Price History
Current Price: $0.83
Price Change: ▼ Price Decrease of -0.0257 (-3.00%)
As of 02/3/2026 05:00 PM ET
Firefly Neuroscience Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 10/22/2025 | Windsor Private Capital Lp | Major Shareholder | Sell | 78,031 | $2.07 | $161,524.17 | 1,236,773 | |
| 10/21/2025 | Windsor Private Capital Lp | Major Shareholder | Sell | 19,222 | $2.40 | $46,132.80 | 1,314,804 | |
| 10/20/2025 | Windsor Private Capital Lp | Major Shareholder | Sell | 33,500 | $2.46 | $82,410.00 | 1,334,026 | |
| 10/17/2025 | Windsor Private Capital Lp | Major Shareholder | Sell | 45,036 | $2.55 | $114,841.80 | 1,367,526 | |
| 10/16/2025 | Windsor Private Capital Lp | Major Shareholder | Sell | 40,139 | $2.65 | $106,368.35 | 1,412,562 | |
| 10/15/2025 | Windsor Private Capital Lp | Major Shareholder | Sell | 17,500 | $2.74 | $47,950.00 | 1,452,701 | |
| 10/14/2025 | Windsor Private Capital Lp | Major Shareholder | Sell | 29,500 | $2.74 | $80,830.00 | 1,470,201 | |
| 10/13/2025 | Windsor Private Capital Lp | Major Shareholder | Sell | 32,136 | $2.65 | $85,160.40 | 1,499,701 | |
| 10/10/2025 | Windsor Private Capital Lp | Major Shareholder | Sell | 74,810 | $2.70 | $201,987.00 | 1,531,837 | |
| 10/9/2025 | Windsor Private Capital Lp | Major Shareholder | Sell | 30,126 | $2.94 | $88,570.44 | 1,606,647 | |
| 9/29/2023 | Gerald James Benoit Jr | CEO | Buy | 11,666 | $15.00 | $174,990.00 | 66,192 | |
Firefly Neuroscience Institutional Trading History
| Reporting Date | Hedge Fund | Shares Held | Market Value | % of Portfolio | Quarterly Change in Shares | Ownership in Company | Details |
|---|
| 11/7/2025 | Vanguard Group Inc. | 503,071 | $1.46M | 0.0% | +393.3% | 3.741% |  |
| 11/6/2025 | Savvy Advisors Inc. | 21,500 | $63K | 0.0% | N/A | 0.160% |  |
| 8/8/2025 | Geode Capital Management LLC | 120,604 | $0.34M | 0.0% | +92.9% | 0.938% |  |
| 4/17/2025 | FNY Investment Advisers LLC | 22,706 | $89K | 0.1% | N/A | 0.195% |  |
| 2/17/2025 | Millennium Management LLC | 43,314 | $0.12M | 0.0% | -23.9% | 0.545% |  |
| 2/17/2025 | Citadel Advisors LLC | 11,334 | $30K | 0.0% | N/A | 0.143% |  |
| 2/12/2025 | Geode Capital Management LLC | 60,242 | $0.16M | 0.0% | +5.0% | 0.758% |  |
| 10/22/2024 | Waldron Private Wealth LLC | 12,000 | $36K | 0.0% | N/A | 1.791% |  |
| 8/1/2024 | Waldron Private Wealth LLC | 30,000 | $62K | 0.0% | +200.0% | 1.490% |  |
| 1/18/2024 | Trueblood Wealth Management LLC | 16,000 | $27K | 0.0% | N/A | 0.796% |  |
Data available starting January 2016
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.
Read More on Firefly Neuroscience
Volume
56,423 shs
Average Volume
90,474 shs
Market Capitalization
$11.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.85
Who are the company insiders with the largest holdings of Firefly Neuroscience?